[Pharmacological studies on a new thiazide diuretic, FT-124 (3-n-pentyl-6-trifluoromethyl-7-sulfanyl-3, 4-dihydro-1,2,4-benzothiadiazine-1, 1-dioxide)].
D000700:Analgesics; D000818:Animals; D001581:Benzothiadiazines / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D002740:Chlorothiazide / Q000494:pharmacology; D004232:Diuretics / Q000494:pharmacology* / Q000627:therapeutic use; D004285:Dogs; D004562:Electrocardiography; D004569:Electroencephalography; D004573:Electrolytes / Q000652:urine; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D006857:Hydroflumethiazide / Q000494:pharmacology; D006977:Hypertension, Renal / Q000188:drug therapy / Q000652:urine; D007275:Injections, Intravenous; D007677:Kidney Function Tests; D008297:Male; D051379:Mice; D010146:Pain / Q000188:drug therapy; D011817:Rabbits; D051381:Rats; D012119:Respiration / Q000187:drug effects; D014599:Uterus / Q000187:drug effects
D000700:Analgesics; D001581:Benzothiadiazines; D004232:Diuretics; D004573:Electrolytes; D006857:Hydroflumethiazide; D002740:Chlorothiazide